Periprostatic adipose tissue is a new topic being investigated to determine its utility in detecting and scoring prostate cancer. In the past, most of the studies related to prostate cancer relied on body mass index (BMI) to measure adiposity but showed conflicting results. In recently published clinical trials, periprostatic adipose tissue has been considered as a risk factor for the development of prostate cancer. These studies shifted the focus of researchers from BMI to periprostatic adipose tissue quantification demonstrating its relation with prostate cancer. Similarly, the study of paracrine effects of organ-associated adipose tissue and its association with cancer has also been the major focus for researchers lately. Adipokines have been linked with numerous carcinogenic mechanisms, such as angiogenesis, cell proliferation, metastasis, and alterations in sex-steroid hormone levels. This article basically reviews the clinical studies which used different imaging modalities to quantify periprostatic adipose tissue and its association with prostate cancer. Also, it further explores the specific roles of several adipokines like leptin, interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) and their mechanism in progression of prostate cancer.
Introduction
According to World Health Organization, in 2016, nearly 2 billion adults worldwide were overweight and, of these, more than half a billion were obese [1] . Obesity is associated with multiple health consequences, including prostate cancer (PCa) [2] . In many developed countries such as United States, prostate cancer is the third leading cause of death in men. It has been estimated that in 2018, there will be 161,360 new cases of prostate cancer and approximately 26,730 people will die of this disease [3] . Its incidence is increasing in developing countries as well.
A rapid increase over the past 20-30 years has been found in Asian men as well, probably due to change in dietary habits, obesity and western sedentary lifestyle [4] .
Adipobiology is a study of endocrine, paracrine and autocrine activities of adipose tissue. Hence, adipoparacrinology is the study of paracrine secretory activities of adipose tissue. It is a new emerging topic in research field [5] . Adipose tissue is of two types; white adipose tissue (WAT) and brown adipose tissue (BAT).
Recently, WAT has been recognized not only as an energy storage but also as the body's major endocrine and paracrine organ [6] . WAT is divided mainly into two large depots; subcutaneous and visceral. Visceral depots constitutes of organ associated adipose tissues like epicardial and periadventitial adipose tissue in atherogenesis, mammary gland-associated adipose tissue in breast cancer, mesenteric adipose tissue in Crohn's disease etc [6] .
Recently, studies on paracrine activities of organ associated adipose tissues demonstrated periprostatic adipose tissue (PPAT) as a source of adipokines like adiponectin, resistin, leptin, and adipsin, and a source of a variety of other cytokines, such as tumor necrosis factor and interleukin-6 (IL-6) which forms a key component in the tumor microenvironment [7] [8] [9] [10] [11] [12] [13] [14] . Several in vivo and in vitro studies have suggested a potential role of periprostatic adipose tissue in the development and progression of PCa [15] [16] [17] . This review highlights the relationship between periprostatic adipose tissue, adipokines and prostate cancer. We reviewed all the clinical studies published till date that have demonstrated PPAT as a risk factor for prostate cancer diagnosis and progression.
Different Approaches and Imaging Modalities for Periprostatic Fat Mapping
Until recently, external adipose tissue has been considered the predictive indicator of obesity and BMI as the anthropometric measure of obesity. Several studies have shown the inconsistent relation between Body Mass Index (BMI) and Prostate Carcinoma (PCa) [18] [19] [20] [21] [22] [23] . Hence, researchers now have shifted their focus on more specific body fat distribution like visceral fat, as it is more active metabolically than subcutaneous fat and produces adipokines, cytokines, tumor necrosis factor, interleukin-6, and adiponectin. They have even considered regional adipose tissue, such as periprostatic fat as an area of interest and taken into account its potential role in the development and progression of PCa.
Woo et al. in 2014 [24] , conducted a retrospective study on patients who underwent MRI before radical prostatectomy to evaluate the relation between periprostatic fat thickness (PPFTh) and Gleason score (GS). They Table 1 : Periprostatic fat mapping methods in previous studies and their outcomes.
They also measured age, height, weight, BMI, PSA to correlate with Gleason score. This study reported a significant correlation of PPFTh with GS and was able to differentiate GS-7 from GS-6. However, BMI and subcutaneous fat thickness were not correlated with GS. Zhang et al. in 2013 [25] , also showed that periprostatic adiposity measured on a single transverse MRI section aids in accurate assessment of stage and grading of PCa. They measured periprostatic fat area including ischiorectal fossae measurements [ Figure 2 ]. Zhang and colleagues [26] from China also performed another similar study using MRI to investigate the correlation of periprostatic fat and PCa aggressiveness and also the role of adipocytokines in stimulating the progression of prostate cancer from lower to higher grades. They were able to justify that the levels of IL-6, leptin and C-reactive expressed as a percentage [25, 26] . The strongest correlation was seen between IL-6 and PPAT.
One study in 2016 by Tan et al. [27] , used reconstructed MRI images to investigate not only periprostatic fat thickness but also periprostatic fat volume and periprostatic fat ratio. This study did not use histopathology of radical prostectomy as a reference standard and thus has limitations. Previously, studies using MRI were much less.
Nowadays, the routine use of MRI in the diagnosis of prostate carcinoma has yielded a more accurate volume of prostate fat. This study has further suggested that periprostatic fat ratio is a better predictor of high grade prostate cancer and has the potential to aid in the decision to biopsy process compared to periprostatic volume.
A very recent study published by Dahran et al. on July 2017 [28] , is a first prospective study that measured periprostatic and pelvic fat volume with normalization to prostate gland volume on MRI (T1-weighted images) and demonstrated significantly strong correlation with GS and PCa. They reported that measuring periprostatic fat volume from prostate base to apex might be time consuming but is most accurate and appropriate, as prostate tumour and cancer-related adipocytes can be located at any level in the gland. The other rationale is that body fat distribution varies between individuals according to age, angiogenesis, adipogenesis, genetic regulation and insulin resistance.
Cao et al. [29] . evaluated periprostatic adipose thickness as a supportive marker in predicting the presence of prostate cancer. Their main aim was to demonstrate that PPFTh may have a pre-biopsy clinical utility to improve the diagnostic abilities of MRI and PI-RADS version 2. Although, the specificity and sensitivity of MRI in the diagnosis of prostate cancer is 88% and 74% as calculated by Rooij M et al. [30] . However, there are certain limitations that MRI and PI-RADS encompasses, among which the inability to accurately determine PIRADS-3 lesion remains a recognized drawback. This study has provided a strong support in the diagnosis of indeterminate lesions of the PI-RADS grade 3 subgroup. They not only demonstrated that age, %fPSA and PPFT were independent predictors of PCa and High Grade PCa (HGPCa) but also suggested that PPFTh is an independent predictor of prostate carcinoma, especially in PIRADS grade 3 subgroup. A millimeter increase in PPFT was associated with 156% increased odds of detecting prostate cancer and 170% increased odds of HGPCa.
Another recent study on 2017 by Salji et al. [31] , used MRI to test if periprostatic fat volume (PPFV) predicts tumor response following androgen deprivation therapy(ADT). They retrospectively collected data of patients with locally advanced or metastatic PCa treated with primary ADT. Periprostatic fat volume was delineated from apex to base.
This study suggested that PPFV measurement can be considered a useful biomarker of CRPC as PPFV was significantly higher in patients who developed Castration resistant advanced prostate cancer. [38] , concluded that periprostatic fat and fat-density measured with CT were not correlated with PC aggressiveness in patients receiving brachytherapy. However, similar study performed in 2010 by the same researchers [39] , reported patients with a higher periprostatic fat density had more aggressive prostate cancer. This discrepancy in the results was attributed to different approaches in mapping the periprostatic fat and different population size.
Allott et al. in 2014 [40] , conducted a cross-sectional analysis between black and non-black men with 308 radiation treated patients. They examined obesity parameters like BMI, waist circumference, visceral fat area and periprostatic adipose tissue area and its association with PCa aggressiveness on CT scan. The results showed black men had significantly less PPAT relative to non-black men but no association between elevated PPAT and increased risk of aggressive PCa were found. Although studies using CT has high risk of exposure to ionizing radiation and also CT is not often used in patients with prostate cancer. However, it is an exceptional modality to assess and accurately CT in evaluating the correlation between PPFTh and PCa. Only 7 studies using MRI, 3 studies using CT and one study using TRUS have been performed to date which has been included in this review.
Mechanism of Adipokines in the Development and Progression of Prostate Cancer
White adipose tissue is composed mostly of adipocytes along with stromal vascular cells like and immune cells such as macrophages, lymphocytes and mast cells [43] . Several bioactive molecules and cell signaling proteins like cytokines, growth factors and hormones jointly termed as adipokines are secreted by adipose tissue. The paracrine activity of adipokines and the endocrine derangements such as increased serum estrogen, insulin, IGF-1 and its cancerogenic effect on the prostate gland is hypothesized to be the basis of correlation between PPAT and PCa in several studies.
Sacca et al. [7] , evaluated the role of periprostatic adipose tissue (PPAT) from patients with Benign Prostate Hyperplaisa (BPH) and compared with PPAT from PCa patients. Their study provided the first evidence that PPAT releases pro-MMP-9, and that PPAT-conditioned media from patients with PCa shows higher activity of pro-MMP-9 than PPAT conditioned media from patients with BPH. This study signifies that the factors released from adipose tissue of PCa can induce disease progression. More than one-third IL-6 circulating in bloodstream are secreted by adipocytes [44, 45] . In vitro studies revealed that both the autocrine and paracrine activities of IL-6 is known to stimulate the growth of human prostate cancer cell lines that leads to hyperplasia of tumor cells [9, 12, 46] . It regulates variety of cellular functions including proliferation, apoptosis, angiogenesis, and differentiation [10] .
Finley et al. [8] were the first to study adipokine levels in PPAT. In their study, they harvested PPAT from patients undergoing Radical prostectomy (RP), and demonstrated that IL-6 in PPAT-conditioned medium was approximately 375 times greater than in patient matched serum. This finding suggests that periprostatic adipose tissue could be regarded as a source of pro-cancerogenic adipokines. This study also suggested the idea of bidirectional interaction of IL-6 between PPAT and prostate tumors. Serum IL-6 levels >7 pg/ml shows poor prognosis in men with prostate cancer and increased levels of IL-6 in localized tumours suggests IL-6 acitivity in the early stages of prostate carcinogenesis [11] [12] .
Leptin is a peptide hormone that regulates energy homeostatis, metabolism and neuroendocrine function. Serum level of leptin in lean individuals is on average 4 ng/ml, whereas obese people show much higher levels around 40 ng/ml [47] . Numerous studies have investigated the relation between leptin and prostate cancer [48] [49] [50] . Chang et al. [13] showed that elevated leptin was found in men with aggressive disease. Another study by SK Singh et al. [14] shows that prostate cancer is associated with raised serum leptin. In vitro studies showed that leptin promotes proliferation of androgen-independent PCa and induces cell migration and expression of growth factors in PCa cells [51] [52] . Saglam et al. [53] also showed that the high leptin influence the progression of a latent PCa to a high grade PCa. Several in vitro and in vivo studies demonstrated that leptin promotes angiogenesis and can aid in the enlargement and metastasis of several neoplasias including PCa [15] [16] [17] .
Angiogenesis and prostate cancer
Vascular endothelial growth factor(VEGF) are important signaling proteins involved in angiogenesis. Tumors induce angiogenesis by secreting VEGF and increasing the number of capillaries which supply nutrients to the tumor for its expansion and progression to aggressive form [54] . Many researches have demonstrated that in the presence of VEGF, endothelial cells will proliferate and migrate forming capillaries [55] [56] [57] . Fernando et al. [58] studied the invivo and invitro expression of angiogenesis which demonstrated that significant levels of VEGF are present in PCa, but not in BPH or normal prostate cells in vivo.
Conclusion
Only few clinical studies to estimate periprostatic adipose tissue parameters (thickness, area, volume, density, ratio, fatty acid composition) have been published. These studies suggest the potential of periprostatic adipose tissue mapping in preoperative assessment of Gleason score and in evaluating PI-RADS grade 3 subgroup lesions. The increasing mortality of men due to prostate cancer demands a new, accurate and reliable predictor for this disease and the convenience in measuring PPF without the need of expertise and invasiveness makes it a more practical and feasible clinical parameter in the prediction of prostate carcinoma. The study of adipoparacrinology and mapping of periprostatic fat provides an auxiliary role in the future diagnosis of prostate carcinoma. Hence, more research regarding this topic is suggested.
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